How do you identify patients with targetable alterations that would suggest their triage into clinical trials?

How do you identify patients with targetable alterations that would suggest their triage into clinical trials?

How do you identify patients with targetable alterations that would suggest their triage into clinical trials?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Lia Tsimberidou, MD, PhD

Lia Tsimberidou, MD, PhD

Tenured Associate Professor
Department of Investigational Cancer Therapeutics
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX